Recombinant Guillardia theta Acyl carrier protein (acpP)

Shipped with Ice Packs
In Stock

Description

Biosynthesis and Expression Systems

Recombinant Production

  • Expression Hosts: Successfully expressed in Escherichia coli BL21 and yeast systems (e.g., Pichia pastoris), leveraging codon optimization for algal genes .

  • Challenges: Poor expression observed in chloroplast-based systems (e.g., Chlamydomonas reinhardtii), attributed to weak promoters (e.g., psbD) and inefficient vector systems .

Activation Requirements

  • PPTase Dependency: Requires co-expression with cognate PPTases (e.g., Sfp-type PptC1/PptC2) for 4'-PP modification .

Research Findings and Applications

Functional Studies

  • Enzyme Activity Assays: Recombinant G. theta acpP demonstrates substrate specificity for C16–C18 acyl chains in vitro, aligning with its role in algal lipid storage .

  • Metabolic Engineering: Integration into synthetic pathways enhances polyketide yields in heterologous hosts .

Table 1: Key Functional Attributes of Guillardia theta acpP

AttributeDetailReference
Molecular Weight~8.9 kDa (unmodified)
PhosphopantetheinylationSerine-36 (conserved across cryptophytes)
Subcellular LocalizationPeriplastid compartment (PPC) / Plastid stroma
Expression HostsE. coli BL21, Pichia pastoris

Evolutionary and Comparative Insights

Phylogenetic Analysis

  • PPTase Compatibility: G. theta acpP is activated by both native cryptophyte PPTases (PptC1/PptC2) and heterologous Sfp-type enzymes, reflecting evolutionary conservation .

  • Divergence from Apicomplexans: Unlike apicomplexan ACPs (e.g., Plasmodium), G. theta acpP retains ancestral plastid-targeting peptides, indicating minimal functional drift .

Table 2: Comparative ACP Features in Algae

SpeciesPPTase TypeLocalizationKey Function
Guillardia thetaSfpPPC/PlastidFatty acid synthesis
Chlamydomonas reinhardtiiSfp/AcpSChloroplastLipid storage
Phaeodactylum tricornutumAcpSMitochondriaSecondary metabolism

Challenges and Future Directions

Expression Optimization

  • Promoter Engineering: Adoption of stronger promoters (e.g., psbA in D1 vectors) could enhance chloroplast-based expression .

  • Fusion Protein Design: Poor expression in fusion constructs (e.g., GGPPS-taxadiene cyclase) highlights the need for linker optimization .

Functional Exploration

  • Proteomic Mapping: Detailed interactome studies are needed to identify partner enzymes in G. theta lipid pathways .

  • Biotechnological Applications: Potential use in biofuel production via metabolic engineering of lipid-rich algal strains .

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult local distributors for specifics. All proteins ship with blue ice packs. Dry ice shipping requires prior arrangement and incurs extra fees.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
acpP; acl1; acpA; Acyl carrier protein; ACP
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-81
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Guillardia theta (Cryptomonas phi)
Target Names
acpP
Target Protein Sequence
MNEQEIFEKV QTIISEQLGV DKSQVTKDAN FANDLGADSL DTVELVMAIE EAFNIEIPDD AAEQISNLQQ AVDFISQKVA A
Uniprot No.

Target Background

Function
Carries the growing fatty acid chain during fatty acid biosynthesis.
Protein Families
Acyl carrier protein (ACP) family
Subcellular Location
Plastid, chloroplast.

Q&A

What is Guillardia theta Acyl carrier protein (acpP) and what is its biological significance?

Guillardia theta Acyl carrier protein (acpP), also known as ACP, is a small acidic protein that plays a critical role in fatty acid biosynthesis pathways. This protein serves as a carrier for growing acyl chains during fatty acid synthesis, with the growing fatty acid chain attached to a phosphopantetheine prosthetic group on the protein .

The biological significance of this protein extends beyond basic metabolism. Guillardia theta, a cryptophyte alga, acquired photosynthesis through secondary endosymbiosis (engulfment of a red algal cell). This evolutionary history makes its metabolic proteins particularly interesting for studying the integration of endosymbiont and host metabolic pathways .

Methodological considerations for studying acpP function:

  • Conduct comparative sequence analysis against other cryptophyte ACPs

  • Express recombinant protein in appropriate host systems (E. coli, yeast, baculovirus, or mammalian cells)

  • Perform activity assays with purified protein to confirm function

  • Use site-directed mutagenesis to identify critical functional residues

How does the genomic context of acpP in Guillardia theta inform its functional role?

The genomic context of acpP in Guillardia theta provides important insights into the evolution of fatty acid biosynthesis in this organism following secondary endosymbiosis.

Guillardia theta possesses multiple genomes - the host nuclear genome, a highly reduced endosymbiont nuclear genome (nucleomorph), and a plastid genome. This compartmentalization raises questions about where acpP is encoded and how its expression is coordinated across these genetic systems .

The plastid genome of Guillardia theta spans 121,524 bp with a G+C content of 32%, containing 147 protein-coding genes with a coding percentage of 87.7% . This genomic organization provides context for understanding the evolution of metabolic genes like acpP after endosymbiotic events.

OrganismSize (bp)G + C%Protein GenestRNAsIR?Coding%
Guillardia theta121,52432%14730Yes87.7%
Rhodomonas salina135,85434%14631Yes80.8%
Cryptomonas paramecium77,71738%8229No87.0%

Methodological approaches for genomic analysis:

  • Perform comparative genomic analysis across cryptophyte species

  • Use transcriptome profiling to identify patterns of co-expression

  • Employ fluorescence in situ hybridization to locate the gene within cellular compartments

  • Analyze promoter regions to identify regulatory elements

What are the optimal conditions for handling recombinant Guillardia theta acpP in laboratory settings?

Working with recombinant Guillardia theta Acyl carrier protein requires careful attention to storage and handling conditions to maintain protein integrity and activity:

  • Storage recommendations:

    • Store stock solutions at -20°C for long-term storage

    • For extended preservation, store at -80°C

    • Maintain working aliquots at 4°C for up to one week

    • Avoid repeated freezing and thawing cycles that can compromise protein structure and function

  • Buffer considerations:

    • The commercial preparation is typically supplied as a liquid containing glycerol

    • For functional studies, phosphate buffers at pH 7.0-7.5 are recommended

    • Addition of reducing agents (e.g., DTT or β-mercaptoethanol) may help maintain protein stability

  • Experimental handling:

    • Confirm protein purity (commercial preparations typically exceed 90%)

    • Validate functional activity before use in complex experimental systems

    • Consider co-factors and post-translational modifications required for activity

Methodological validation approaches:

  • Use mass spectrometry to confirm protein identity and modifications

  • Perform circular dichroism spectroscopy to verify proper protein folding

  • Conduct activity assays to ensure functional competence

How can researchers effectively express and purify functional Guillardia theta acpP?

Expressing functional recombinant Guillardia theta acpP requires careful consideration of expression systems and purification strategies:

  • Expression system selection:

    • E. coli systems are commonly used for initial expression trials

    • Yeast, baculovirus, or mammalian cell systems may provide superior post-translational modifications

    • Consider co-expression of phosphopantetheinyl transferase to ensure proper modification

  • Purification strategy:

    • Design constructs with appropriate affinity tags (His, GST, or MBP)

    • Develop a multi-step purification protocol:

      • Initial capture using affinity chromatography

      • Intermediate purification using ion exchange chromatography

      • Polishing step using size exclusion chromatography

    • Target final purity >90% for functional studies

  • Functional validation:

    • Confirm phosphopantetheine modification using mass spectrometry

    • Verify protein folding using spectroscopic methods

    • Assess activity in reconstituted systems with partner enzymes

Methodological troubleshooting strategies:

  • If protein solubility is low, modify culture conditions (temperature, inducer concentration)

  • For aggregation issues, explore fusion partners or solubility-enhancing tags

  • When activity is suboptimal, assess post-translational modification status

What analytical methods are most effective for studying interactions between Guillardia theta acpP and partner proteins?

Understanding protein-protein interactions involving acpP is critical for characterizing its role in fatty acid biosynthesis:

  • Qualitative interaction methods:

    • Yeast two-hybrid screening for initial identification of binding partners

    • Pull-down assays using tagged recombinant acpP

    • Co-immunoprecipitation with specific antibodies

    • Proximity ligation assays for in situ detection

  • Quantitative interaction analysis:

    • Surface plasmon resonance (SPR) for real-time binding kinetics

    • Isothermal titration calorimetry (ITC) for thermodynamic parameters

    • Microscale thermophoresis for interactions in complex solutions

    • Fluorescence resonance energy transfer (FRET) for dynamic studies

  • Structural characterization approaches:

    • X-ray crystallography of acpP-enzyme complexes

    • NMR spectroscopy for solution-state interaction mapping

    • Hydrogen-deuterium exchange mass spectrometry (HDX-MS) for interface mapping

    • Cross-linking coupled with mass spectrometry for identifying interaction sites

Methodological recommendations:

  • Begin with multiple screening approaches to identify candidate interactions

  • Validate key interactions using orthogonal methods

  • Characterize binding parameters (Kd, kon, koff) for critical interactions

  • Develop structural models of complexes to guide functional studies

How does the evolution of Guillardia theta acpP reflect its unique endosymbiotic history?

The evolutionary trajectory of Guillardia theta acpP provides insights into metabolic integration following secondary endosymbiosis:

  • Evolutionary context:

    • Guillardia theta acquired photosynthesis through engulfment of a red algal cell

    • Cryptophytes like G. theta uniquely retain the nucleomorph (reduced endosymbiont nucleus)

    • This complex cellular organization creates opportunities for novel metabolic pathway arrangements

  • Comparative analysis framework:

    • Align acpP sequences from primary (red and green algae) and secondary endosymbionts

    • Identify conserved functional domains versus lineage-specific adaptations

    • Analyze selection pressures using dN/dS ratios across phylogenetic trees

    • Map key adaptations to three-dimensional protein structures

  • Functional implications:

    • Determine subcellular localization of acpP isoforms

    • Assess functional complementation between acpP variants from different compartments

    • Investigate coordination of fatty acid synthesis across compartmental boundaries

Methodological strategies:

  • Use phylogenomic approaches to reconstruct evolutionary history

  • Employ ancestral sequence reconstruction to infer functional shifts

  • Perform comparative biochemical assays to identify functional differences

  • Develop compartment-specific expression systems to test localization hypotheses

How can structural characterization of Guillardia theta acpP advance understanding of cryptophyte metabolism?

Structural studies of Guillardia theta acpP can reveal unique adaptations related to its function in cryptophyte metabolism:

Methodological workflow recommendations:

  • Begin with homology modeling based on known ACP structures

  • Validate models using experimental techniques (CD spectroscopy, limited proteolysis)

  • Progress to high-resolution structural studies of the native protein

  • Extend to complex formation with partner enzymes

What methodological approaches can resolve conflicting data in Guillardia theta acpP research?

Resolving contradictions and inconsistencies in acpP research requires systematic methodological approaches:

  • Source of contradictions in acpP research:

    • Differences in expression systems affecting post-translational modifications

    • Variations in assay conditions altering apparent activity

    • Misidentification of specific acpP isoforms among multiple variants

    • Cross-reactivity issues with antibodies or detection reagents

  • Systematic resolution framework:

    • Standardize expression systems and purification protocols

    • Establish consistent assay conditions across research groups

    • Sequence-verify all genetic constructs before functional studies

    • Develop isoform-specific detection methods

  • Validation strategies:

    • Perform side-by-side comparisons of conflicting protocols

    • Use multiple orthogonal techniques to verify key findings

    • Conduct interlaboratory validation studies for critical results

    • Generate knockout/knockdown models to confirm phenotypes

Methodological best practices:

  • Maintain detailed records of all experimental conditions

  • Share standardized materials (plasmids, antibodies) between laboratories

  • Develop quantitative assays with clear positive and negative controls

  • Consider environmental and host-specific factors that may influence results

How can Guillardia theta acpP be utilized for studying endosymbiotic gene transfer?

Guillardia theta acpP serves as an excellent model for studying endosymbiotic gene transfer due to the organism's unique evolutionary history:

  • Research applications:

    • Tracing gene transfer events from endosymbiont to host genomes

    • Investigating coordination of gene expression across multiple genomic compartments

    • Studying the evolution of targeting sequences for protein localization

    • Examining how metabolic pathway components become integrated post-endosymbiosis

  • Experimental approaches:

    • Perform comprehensive genomic and transcriptomic analyses across cryptophyte species

    • Develop fluorescently tagged constructs to track protein localization

    • Use genetic transformation to test functional complementation across species

    • Employ comparative biochemistry to identify functional adaptations

  • Evolutionary insights:

    • Compare acpP genomic context in primary and secondary endosymbionts

    • Analyze selection pressures before and after endosymbiotic events

    • Identify signatures of horizontal gene transfer versus vertical inheritance

    • Reconstruct ancestral sequences to infer functional shifts

Methodological considerations:

  • Develop model systems amenable to genetic manipulation

  • Establish phylogenetically informed sampling strategies

  • Apply computational approaches to predict gene transfer events

  • Combine molecular and cellular approaches to validate predictions

What techniques are most effective for studying post-translational modifications of Guillardia theta acpP?

Post-translational modifications, particularly phosphopantetheinylation, are critical for acpP function and require specialized analytical approaches:

  • Identification methods:

    • Mass spectrometry to detect the 4'-phosphopantetheine modification

    • Activity-based protein profiling using chemical probes

    • Gel mobility shift assays to distinguish apo- and holo-forms

    • Radiolabeling approaches to track modification kinetics

  • Quantification strategies:

    • Multiple reaction monitoring (MRM) mass spectrometry for absolute quantification

    • Spectrophotometric assays using specific substrates

    • Fluorescence-based assays with environmentally sensitive probes

    • Western blotting with modification-specific antibodies

  • Functional correlation techniques:

    • Site-directed mutagenesis of modification sites

    • In vitro reconstitution with purified modification enzymes

    • Characterization of modification-deficient variants

    • Time-resolved analysis of modification dynamics

Methodological workflow:

  • Express and purify recombinant acpP in appropriate host systems

  • Perform in vitro modification reactions with purified phosphopantetheinyl transferases

  • Develop analytical methods to distinguish and quantify modified versus unmodified forms

  • Correlate modification status with functional activity in reconstituted systems

What are the primary technical challenges in working with Guillardia theta acpP and how can they be overcome?

Working with Guillardia theta acpP presents several technical challenges that require specific methodological solutions:

  • Expression and solubility issues:

    • Problem: Low expression yields or formation of inclusion bodies

    • Solutions:

      • Optimize codon usage for expression host

      • Use solubility-enhancing fusion partners (MBP, SUMO)

      • Express at lower temperatures (15-18°C)

      • Screen multiple expression hosts (E. coli, yeast, baculovirus, mammalian cells)

  • Post-translational modification challenges:

    • Problem: Incomplete phosphopantetheinylation

    • Solutions:

      • Co-express with phosphopantetheinyl transferase

      • Perform in vitro modification reactions

      • Develop chromatographic methods to separate apo- and holo-forms

      • Use enzymatic assays to quantify active holo-protein percentage

  • Functional assay limitations:

    • Problem: Difficult to reconstitute complete fatty acid synthesis pathway

    • Solutions:

      • Develop targeted assays for specific reaction steps

      • Use surrogate substrates for activity measurements

      • Create chimeric proteins with well-characterized domains

      • Implement cell-free expression systems with coupled activity assays

Methodological recommendations:

  • Begin with small-scale expression trials to optimize conditions

  • Develop robust purification protocols that maintain protein stability

  • Establish clear quality control metrics before proceeding to functional studies

  • Consider synthetic biology approaches for pathway reconstitution

How might emerging technologies advance Guillardia theta acpP research in the next decade?

Emerging technologies are poised to transform research on Guillardia theta acpP and related proteins:

  • Advanced structural biology approaches:

    • Cryo-electron microscopy for visualizing acpP in larger complexes

    • Integrative structural biology combining multiple experimental techniques

    • Time-resolved structural methods to capture conformational dynamics

    • Computational approaches for predicting interaction networks

  • Single-cell and spatial technologies:

    • Single-cell transcriptomics to analyze expression variability

    • Spatial proteomics to map subcellular localization with high precision

    • Super-resolution microscopy to visualize protein-protein interactions in situ

    • Live-cell imaging to track acpP dynamics in real-time

  • Synthetic biology and genome engineering:

    • CRISPR-Cas9 systems adapted for cryptophyte genome editing

    • Cell-free protein synthesis for high-throughput functional screening

    • Synthetic pathway reconstruction to test functional hypotheses

    • Genetically encoded biosensors for monitoring acpP activity

  • Computational and systems biology:

    • Machine learning approaches for predicting protein-protein interactions

    • Multi-scale modeling of metabolic networks spanning compartmental boundaries

    • Evolutionary simulations to reconstruct adaptive trajectories

    • Network biology to understand pathway integration after endosymbiosis

Future research directions:

  • Developing cryptophyte genetic manipulation systems

  • Creating synthetic minimal systems for fatty acid synthesis

  • Exploring applications in metabolic engineering

  • Investigating the role of acpP in environmental adaptation

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.